Lymphokine-activated Killer (LAK) Activity Against Autologous Malignant Tumors of the Skin

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

1982 • 2,228 citations

Textbook of dermatology

1968 • 1,648 citations

Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis.

1986 • 698 citations

Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor.

1981 • 516 citations

Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells

1983 • 477 citations

Lymphokine-activated killer cells. Analysis of progenitors and effectors.

1986 • 403 citations

Cytotoxicity of interleukin 2-activated lymphocytes for leukemia and lymphoma cells

1986 • 179 citations

Phenotypic dynamics of tumor progression in human malignant melanoma

1985 • 172 citations

Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.

1986 • 166 citations

Lymphokine-activated killer (LAK) cells. Analysis of factors relevant to the immunotherapy of human cancer

1985 • 130 citations

Destruction of autologous human lymphocytes by interleukin 2-activated cytotoxic cells.

1986 • 116 citations

Lymphokine activated killer cells

1989 • 113 citations

The human lymphokine-activated killer cell system

1985 • 71 citations

Characterization and modulation of human lymphokine (interleukin 2) activated killer cell induction.

1986 • 59 citations

Interleukin 2-activated killer cells: generation in collaboration with interferon? and its suppression in cancer patients

1986 • 39 citations

Diminished interleukin-2 activity production in cancer patients bearing solid tumors and its relationship with natural killer cells

1983 • 37 citations

Lymphokine activated killing of fresh human leukaemias

1986 • 36 citations

Interleukin-2 and lymphokine activated killer (LAK) cells in the treatment of malignant glioma: clinical and experimental studies

1986 • 35 citations

Regulation of Natural Killer Cell Function by Glass-adherent Cells in patients with Primary Intracranial Malignancies

1984 • 26 citations

Carcinoembryonic antigen in skin and related tumours as determined by immunohistological techniques

1983 • 13 citations

The Interaction of Recombinant IL‐2 with Human Resting Lymphocytes

1987 • 7 citations

Interleukin-2 activated peripheral blood lymphocytes and the correlation of lytic activity and peanut agglutinin receptor expression on malignant cells.

1984 • 6 citations